Head of Commercial Development, Gene Editing and Novel Modalities, MilliporeSigma
David Backer is Head of Commercial Development at MilliporeSigma for its Gene Editing and Novel Modalities Promise Venture, which includes cell and gene therapy development and GMP manufacturing. Previous positions within MilliporeSigma include operational, sales, and marketing positions for emerging technologies. Dave was founder and President of Molecular Medicine BioServices, which is a CDMO based in Carlsbad, CA and is now part of the BioReliance services offer. Dave has a BS in Cellular and Molecular Biology from the University of Michigan and an MBA from the University of Chicago.